Wet AMD

Related

• 

  Should We Ever Consider Stopping Treatment for Neovascular AMD?

  Rahul N. Khurana, MD, FASRS

  Updates from the Field

  2020

• 

  Apples and Oranges: "Real-World" Outcomes Differ From Clinical Trial Outcomes Because "Real-World" Patients Differ From Clinical Trial Patients

  Franco M. Recchia, MD

  Annual Meeting Talks

  2021

• 

  Two-Year Results From the Subretinal RGX-314 Gene Therapy Phase 1/2a Study for the Treatment of Neovascular AMD

  Robert L. Avery, MD

  Updates from the Field

  2021